0

Industry Groups Challenge Readiness of ICER’s Value Framework

Healthcare is all about making decisions. Who to treat? When to treat? How to treat? How long to treat? How much to spend to treat? The list goes on and on. Fortunately, great strides have been made in healthcare decision… Continue Reading

0

Good, Bad, or Indifferent on Drug Pricing: A Value Benchmark Approach for Newly Launched Drugs in the United States.

Hardly a day goes by without a new article being published in the mainstream press or a medical journal discussing drug pricing.  The cost of drugs is a hot potato topic at medical meetings, pharma conference rooms, government hearings, and… Continue Reading

0

Achieving Market Access in India – Are You Hitting the Mark? An Interview with Marksman Healthcare Solutions CEO Dr. Amit Dang

It’s well-accepted that the Indian pharmaceuticals market cannot be ignored.  India will be one of the top 10 sales markets by 2020, fueled by the rapid growth in its population and economy.  Commensurately, India is experiencing expansion within its middle-class… Continue Reading

0

Secrets of Success: How EPI-Q Does Real-World Research Really Well

Nothing beats experience.  Well, maybe a list of secrets learned from that experience, compiled directly from an expert!  And that’s what you’ll get here, in today’s blog post. I recently conducted a podcast with Dr. Mark Jewell, President of EPI-Q,… Continue Reading